CR Intrinsic Investors’s MetLife MET Stock Holding History

CR Intrinsic Investors’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-119,269	Closed	-$4.86M	–	376
2013 Q2	$4.86M	Buy	+119,269	New	+$4.39M	0.17%	184

Other funds holding MET

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

CR Intrinsic Investors's MET Position: Q3 2013 in Review

CR Intrinsic Investors sold out of MetLife (MET) in Q3 2013, closing a stake of 119,269 shares — an estimated $4.86M sold.

CR Intrinsic Investors first reported a position in MET in Q2 2013 and held it in 1 quarter. The position peaked at $4.86M in Q2 2013. 849 funds tracked by Wall St. Rank hold MET as of Q3 2013.

CR Intrinsic Investors reported no remaining MetLife position as of Q3 2013 after selling out during the quarter.
CR Intrinsic Investors sold 119,269 MetLife shares in Q3 2013, an estimated $4.86M.
CR Intrinsic Investors first reported a position in MetLife in Q2 2013 and held it in 1 quarter.
CR Intrinsic Investors's MetLife position peaked at $4.86M in Q2 2013.
849 funds tracked by Wall St. Rank held MetLife as of Q3 2013.

Based on CR Intrinsic Investors's 13F filing for Q3 2013, filed 14 Nov 2013.